Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

DeGuise

Showing results (1-10 of 67) with videos related to

Pageof 7
Sort By:
Comprehensive Physiology|August 25, 2025
The Role of Mesenchymal Stromal Cells in the Treatment of Bronchopulmonary Dysplasia: A Multi-Prong Approach for a Heterogeneous DiseaseMarc-Olivier Deguise, Bernard Thébaud
Annals of Clinical and Translational Neurology|July 12, 2017
New insights into SMA pathogenesis: immune dysfunction and neuroinflammationMarc-Olivier Deguise, Rashmi Kothary
Seminars in Perinatology|March 7, 2025
NIPPV vs CPAP: Lessons from meta-analysesMarc-Olivier Deguise, Brigitte Lemyre
The Canadian Journal of Cardiology|December 1, 1990
Cardiobacterium hominis endocarditisM DeGuise, G Lalonde, Y Girouard
The Journal of Invasive Cardiology|April 4, 2000
Successful balloon angioplasty of in-stent restenosis of left internal mammary arteryB Chandrasekar, P deGuise, S Doucet
Conservation Biology : the Journal of the Society for Conservation Biology|August 17, 2006
Protected areas and prospects for endangered species conservation in CanadaIsabelle E Deguise, Jeremy T Kerr
International Journal of Molecular Sciences|June 2, 2021
Metabolic Dysfunction in Spinal Muscular AtrophyMarc-Olivier Deguise, Lucia Chehade, Rashmi Kothary
Journal of Neuromuscular Diseases|April 26, 2020
Blood Flow to the Spleen is Altered in a Mouse Model of Spinal Muscular AtrophyMarc-Olivier Deguise, Ariane Beauvais, Bernard L Schneider, et al.
Frontiers in Medicine|March 20, 2023
JAK inhibitors: A new dawn for oral therapies in inflammatory bowel diseasesClaudia Herrera-deGuise, Xavier Serra-Ruiz, Ernesto Lastiri, et al.
Journal of Gastroenterology and Hepatology|October 11, 2014
Predictive value of early restoration of quality of life in Crohn's disease patients receiving antitumor necrosis factor agentsClaudia Herrera-deGuise, Francesc Casellas, Virginia Robles, et al.
Pageof 7

Showing results (1-10 of 67) with videos related to

Sort By:
Pageof 7
Comprehensive Physiology|August 25, 2025
The Role of Mesenchymal Stromal Cells in the Treatment of Bronchopulmonary Dysplasia: A Multi-Prong Approach for a Heterogeneous DiseaseMarc-Olivier Deguise, Bernard Thébaud
Annals of Clinical and Translational Neurology|July 12, 2017
New insights into SMA pathogenesis: immune dysfunction and neuroinflammationMarc-Olivier Deguise, Rashmi Kothary
Seminars in Perinatology|March 7, 2025
NIPPV vs CPAP: Lessons from meta-analysesMarc-Olivier Deguise, Brigitte Lemyre
The Canadian Journal of Cardiology|December 1, 1990
Cardiobacterium hominis endocarditisM DeGuise, G Lalonde, Y Girouard
The Journal of Invasive Cardiology|April 4, 2000
Successful balloon angioplasty of in-stent restenosis of left internal mammary arteryB Chandrasekar, P deGuise, S Doucet
Conservation Biology : the Journal of the Society for Conservation Biology|August 17, 2006
Protected areas and prospects for endangered species conservation in CanadaIsabelle E Deguise, Jeremy T Kerr
International Journal of Molecular Sciences|June 2, 2021
Metabolic Dysfunction in Spinal Muscular AtrophyMarc-Olivier Deguise, Lucia Chehade, Rashmi Kothary
Journal of Neuromuscular Diseases|April 26, 2020
Blood Flow to the Spleen is Altered in a Mouse Model of Spinal Muscular AtrophyMarc-Olivier Deguise, Ariane Beauvais, Bernard L Schneider, et al.
Frontiers in Medicine|March 20, 2023
JAK inhibitors: A new dawn for oral therapies in inflammatory bowel diseasesClaudia Herrera-deGuise, Xavier Serra-Ruiz, Ernesto Lastiri, et al.
Journal of Gastroenterology and Hepatology|October 11, 2014
Predictive value of early restoration of quality of life in Crohn's disease patients receiving antitumor necrosis factor agentsClaudia Herrera-deGuise, Francesc Casellas, Virginia Robles, et al.
Pageof 7